| Analysis | Metabolite Name | Measured Value | Units | Source |
|---|---|---|---|---|
| GCMS positive ion mode | oxoproline | 43329.1435 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 45676.23928 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 56331.43493 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 56902.67559 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 57859.31487 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 59324.92952 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 59372.31957 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 61140.12909 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 62522.33192 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 63335.64054 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 63673.86251 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 65202.38842 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 67197.74588 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 67359.4391 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 67662.47071 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 68015.98635 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 69465.82371 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 70433.54127 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 70806.97128 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 70882.92087 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 71572.7599 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 72006.03238 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 72263.30356 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 72673.11764 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 72819.60228 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 73284.24078 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 73866.90773 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 74302.29161 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 74700.77164 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 76170.56555 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 76473.8668 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 76859.90787 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 77477.08992 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 79667.25568 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 82654.11628 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 83641.39584 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 84472.7301 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 85253.41492 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 85435.67881 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 85632.62786 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 87266.21252 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 88354.88208 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 90779.92092 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 93704.19852 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 94182.68399 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 97271.10525 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 99153.71634 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 100363.3067 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 100638.2796 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 102613.8408 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 104742.726 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 106647.8995 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 107501.7283 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 110045.5552 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 110056.04 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 110598.1942 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 114246.5899 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 138247.7342 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | oxoproline | 138778.0856 | Peak area | Group 1 - Human Serum |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|